HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haddad, L. Articles by Hopkins, P. N. Search for Related Content PubMed PubMed Citation Articles by Haddad, L. Articles by Hopkins, P. N. Social Bookmarking                      What's this?

The Journal of Lipid Research, Vol. 40, 1113-1122, June 1999
Copyright © 1999 by Lipid Research, Inc.

Original Article

Evidence for a third genetic locus causing familial hypercholesterolemia: a non-LDLR, non-APOB kindred

Correspondence to: P. N. Hopkins

Monogenically inherited hypercholesterolemia is most commonly caused by mutations at the low density lipoprotein receptor (LDLR) locus causing familial hypercholesterolemia (FH) or at the apolipoprotein B (APOB) locus causing the disorder familial defective apoB (FDB). Probands from 47 kindreds with a strict clinical diagnosis of FH were selected from the Cardiovascular Genetics Research Lipid Clinic, Utah, for molecular genetic analysis. Using a combination of single-strand conformation polymorphism (SSCP) and direct sequencing, 12 different LDLR gene mutations were found in 16 of the probands. Three of the probands were carriers of the APOB R3500Q mutation. In five of the remaining 28 pedigrees where no mutation had been detected, samples from enough relatives were available to examine co-segregation with the LDLR region using the microsatellite marker D19S221, which is within 1 Mb centromeric of the LDLR locus, and D19S394, sited within 150 kb telomeric of the LDLR locus. In four of the families there was strong evidence for co-segregation between the LDLR locus and the phenotype of hypercholesterolemia, but in one large family with 18 living affected members and clear-cut bimodal hypercholesterolemia, there were numerous exclusions of co-segregation. Using length polymorphic markers within and outside the APOB gene, linkage of phenotype in this family to the APOB region was similarly excluded. In this large family, the degree of hypercholesterolemia, prevalence of tendon xanthomata, and occurrence of early coronary disease were indistinguishable from the other families studied.

In summary, the data provide unequivocal evidence that a third locus can be etiological for monogenic familial hypercholesterolemia and should be reinvigorating to research in this field.—Haddad, L., I. N. M. Day, S. Hunt, R. R. Williams, S. E. Humphries, and P. N. Hopkins. Evidence for a third genetic locus causing familial hypercholesterolemia: a non-LDLR, non-APOB kindred. J. Lipid Res. 1999. 40: 1113–1122.

Supplementary key words: familial hypercholesterolemia, LDLR gene, APOB gene, microsatellites

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Garg and V. Simha Update on Dyslipidemia J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1581 - 1589. [Abstract] [Full Text] [PDF]

				R. P. Naoumova, I. Tosi, D. Patel, C. Neuwirth, S. D. Horswell, A. D. Marais, C. van Heyningen, and A. K. Soutar Severe Hypercholesterolemia in Four British Families With the D374Y Mutation in the PCSK9 Gene: Long-Term Follow-Up and Treatment Response Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2654 - 2660. [Abstract] [Full Text] [PDF]

				X.-M. Sun, E. R. Eden, I. Tosi, C. K. Neuwirth, D. Wile, R. P. Naoumova, and A. K. Soutar Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia Hum. Mol. Genet., May 1, 2005; 14(9): 1161 - 1169. [Abstract] [Full Text] [PDF]

				K. N. Maxwell and J. L. Breslow Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype PNAS, May 4, 2004; 101(18): 7100 - 7105. [Abstract] [Full Text] [PDF]

				C. Gagne, D. Gaudet, E. Bruckert, and for the Ezetimibe Study Group Efficacy and Safety of Ezetimibe Coadministered With Atorvastatin or Simvastatin in Patients With Homozygous Familial Hypercholesterolemia Circulation, May 28, 2002; 105(21): 2469 - 2475. [Abstract] [Full Text] [PDF]

				P Y Muller and A R Miserez Identification of mutations in the gene encoding sterol regulatory element binding protein (SREBP)-2 in hypercholesterolaemic subjects J. Med. Genet., April 1, 2002; 39(4): 271 - 275. [Abstract] [Full Text] [PDF]

				I. N M Day and D. I Wilson Science, medicine, and the future: Genetics and cardiovascular risk BMJ, December 15, 2001; 323(7326): 1409 - 1412. [Full Text] [PDF]

				F. J. Chaves, J. T. Real, A. B. Garcia-Garcia, M. Civera, M. E. Armengod, J. F. Ascaso, and R. Carmena Genetic Diagnosis of Familial Hypercholesterolemia in a South European Outbreed Population: Influence of Low-Density Lipoprotein (LDL) Receptor Gene Mutations on Treatment Response to Simvastatin in Total, LDL, and High-Density Lipoprotein Cholesterol J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4926 - 4932. [Abstract] [Full Text] [PDF]

				C. Ko, T.-L. Lee, P. W. Lau, J. Li, B. T. Davis, E. Voyiaziakis, D. B. Allison, S. C. Chua , Jr., and L.-S. Huang Two novel quantitative trait loci on mouse chromosomes 6 and 4 independently and synergistically regulate plasma apoB levels J. Lipid Res., May 1, 2001; 42(5): 844 - 855. [Abstract] [Full Text]

				J.-P. Rabes, M. Varret, M. Devillers, P. Aegerter, L. Villeger, M. Krempf, C. Junien, and Catherine Boileau R3531C Mutation in the Apolipoprotein B Gene Is Not Sufficient to Cause Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., October 1, 2000; 20 (10): e76 - e82. [Abstract] [Full Text] [PDF]

				S. Bertolini, A. Cantafora, M. Averna, C. Cortese, C. Motti, S. Martini, G. Pes, A. Postiglione, C. Stefanutti, I. Blotta, et al. Clinical Expression of Familial Hypercholesterolemia in Clusters of Mutations of the LDL Receptor Gene That Cause a Receptor-Defective or Receptor-Negative Phenotype Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20 (9): e41 - e52. [Abstract] [Full Text] [PDF]

				R. Thiart, C. L Scholtz, J. Vergotine, C. F Hoogendijk, J N. P de Villiers, H. Nissen, K. Brusgaard, D. Gaffney, M. S Hoffs, W J H. Vermaak, et al. Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia J. Med. Genet., July 1, 2000; 37(7): 514 - 519. [Abstract] [Full Text]

				S. C. Hunt, P. N. Hopkins, K. Bulka, M. T. McDermott, T. L. Thorne, B. B. Wardell, B. R. Bowen, D. G. Ballinger, M. H. Skolnick, and M. E. Samuels Genetic Localization to Chromosome 1p32 of the Third Locus for Familial Hypercholesterolemia in a Utah Kindred Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1089 - 1093. [Abstract] [Full Text] [PDF]